We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$374M
AUM Growth
+$15.5M
Cap. Flow
-$2.37M
Cap. Flow %
-0.63%
Top 10 Hldgs %
58.23%
Holding
131
New
17
Increased
44
Reduced
24
Closed
14
Avg Time Held
4.6 quarters
Top 10 Avg Time Held
4.2 quarters
Top 20 Avg Time Held
4.7 quarters

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$9.91M
2
SE icon
Sea Limited
SE
+$4.23M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$3.68M
4
CPNG icon
Coupang
CPNG
+$3.22M
5
ROIV icon
Roivant Sciences
ROIV
+$3.13M

Top Sells

Rank Stock Value
1
ROKU icon
Roku
ROKU
+$10.8M
2
SPOT icon
Spotify
SPOT
+$10.1M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.21M
4
MRK icon
Merck
MRK
+$5.24M
5
HTZWW icon
Hertz Global Holdings Warrants
HTZWW
+$3.08M

Sector Composition

Rank Sector Weight
1 Healthcare 28.06%
2 Technology 25.23%
3 Consumer Discretionary 19.31%
4 Communication Services 15.2%
5 Miscellaneous 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SPOT icon
1
Spotify
SPOT
$108B
$44.9M 11.98%
170,000
-43,000
-20% -$10.1M
2021 Q4
9 quarters
SHOP icon
2
Shopify
SHOP
$227B
$32M 8.55%
415,000
– –
2021 Q4
9 quarters
TSLA icon
3
Tesla
TSLA
$1.48T
$29.7M 7.93%
169,000
+50,700
+43% +$9.91M
2022 Q4
5 quarters
AMZN icon
4
Amazon
AMZN
$2.79T
$25.4M 6.79%
141,000
– –
2022 Q3
6 quarters
OXY.WS icon
5
Occidental Petroleum Corp Warrants
OXY.WS
$37.3B
$21.4M 5.71%
496,207
– –
2021 Q4
9 quarters
SNOW icon
6
Snowflake
SNOW
$126B
$20.8M 5.57%
129,000
– –
2021 Q4
9 quarters
PRQR icon
7
ProQR Therapeutics
PRQR
$209M
$12.2M 3.27%
5,344,446
– –
2021 Q4
9 quarters
SE icon
8
Sea Limited
SE
$58.8B
$11.3M 3.01%
210,000
+92,000
+78% +$4.23M
2023 Q2
3 quarters
PLTR icon
9
Palantir
PLTR
$501B
$10.2M 2.73%
445,000
+20,000
+5% +$426K
2023 Q2
3 quarters
RARE icon
10
Ultragenyx Pharmaceutical
RARE
$1.47B
$10M 2.68%
215,102
+48,596
+29% +$2.29M
2021 Q4
9 quarters
IONS icon
11
Ionis Pharmaceuticals
IONS
$7.04B
$9.84M 2.63%
226,993
+9,500
+4% +$453K
2021 Q4
9 quarters
GOOGL icon
12
Alphabet (Google) Class A
GOOGL
$4.33T
$9.06M 2.42%
60,000
-10,000
-14% -$1.43M
2021 Q4
9 quarters
DDOG icon
13
Datadog
DDOG
$102B
$8.16M 2.18%
65,993
– –
2022 Q4
5 quarters
ARWR icon
14
Arrowhead Research
ARWR
$8.21B
$7.83M 2.09%
273,936
– –
2021 Q4
9 quarters
ITCI icon
15
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$7.53M 2.01%
108,883
+14,900
+16% +$1.02M
2023 Q2
3 quarters
NET icon
16
Cloudflare
NET
$124B
$7.26M 1.94%
75,000
– –
2021 Q4
9 quarters
AXSM icon
17
Axsome Therapeutics
AXSM
$8.19B
$6.55M 1.75%
82,032
+10,000
+14% +$839K
2023 Q1
4 quarters
RCKT icon
18
Rocket Pharmaceuticals
RCKT
$252M
$6.33M 1.69%
235,050
+2,000
+0.9% +$56.8K
2022 Q2
7 quarters
MRK icon
19
Merck
MRK
$350B
$6M 1.6%
45,497
-42,481
-48% -$5.24M
2021 Q4
9 quarters
ROIV icon
20
Roivant Sciences
ROIV
$24.1B
$5.98M 1.6%
567,795
+290,000
+104% +$3.13M
2023 Q4
1 quarter
NVDA icon
21
NVIDIA
NVDA
$5.52T
$5.42M 1.45%
60,000
-12,000
-17% -$870K
2023 Q1
4 quarters
FUSN icon
22
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$5.35M 1.43%
251,158
+109,408
+77% +$1.31M
2023 Q4
1 quarter
CRWD icon
23
CrowdStrike
CRWD
$267B
$4.81M 1.28%
60,000
-4,000
-6% -$306K
2021 Q4
9 quarters
MSFT icon
24
Microsoft
MSFT
$4.04T
$4.38M 1.17%
10,400
-5,600
-35% -$2.27M
2023 Q1
4 quarters
MRNA icon
25
Moderna
MRNA
$86.3B
$4.25M 1.13%
39,861
-4,000
-9% -$403K
2022 Q1
8 quarters
1
2 3 4 5

Similar funds

RWMH
Riverpoint Wealth Management Holdings Chicago, Illinois $544M AUM 20.39% 1-Year Est. Return
BPIA
Broad Peak Investment Advisers Singapore $544M AUM 132.56% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $544M AUM 70.51% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $544M AUM 40.38% 1-Year Est. Return
FIM
FWL Investment Management Dallas, Texas $545M AUM 64.06% 1-Year Est. Return
DKAM
Drummond Knight Asset Management Crows Nest, NSW, Australia $545M AUM 73.62% 1-Year Est. Return
CCM
Coerente Capital Management Toronto, Ontario, Canada $543M AUM 7.53% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Privium Fund Management's Q1 2024 Portfolio in Review

As of Q1 2024, Privium Fund Management held 131 positions worth $374M, up 4.3% from $359M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Privium Fund Management's Q1 2024 filing shows 17 new, 44 increased, 24 reduced and 14 closed positions. Its largest new stake was Acadia Pharmaceuticals: 148,400 shares worth $2.74M. The largest sale was Roku, an estimated $10.8M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Privium Fund Management's largest Q1 2024 buy was Acadia Pharmaceuticals: 148,400 shares worth $2.74M.
  • Privium Fund Management added most to Tesla in Q1 2024, an estimated $9.91M increase.
  • Privium Fund Management's biggest Q1 2024 reduction was Spotify, cutting an estimated $10.1M.
  • Privium Fund Management fully exited Roku in Q1 2024, selling an estimated $10.8M.
  • Privium Fund Management's ten largest holdings make up 58% of its $374M portfolio in Q1 2024.
  • Privium Fund Management opened 17 new positions and closed 14 in Q1 2024.
  • Privium Fund Management's portfolio value rose 4.3% quarter-over-quarter to $374M.

Based on Privium Fund Management's 13F filing for Q1 2024, filed 30 Apr 2024.